AzTrials
AzTrials

ACL InjuryNCT04937517

ADC in Assessing Femoral Tunnel Position

An observational study of ACL Injury, run by Peking University Third Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To examine the consistency between postoperative CT scan and intraoperative arthroscopic measurement in evaluating femoral tunnel position for anterior cruciate ligament (ACL)reconstruction,both using the apex of the deep cartilage(ADC)as the marker. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
ACL Injury
How many people
52 participants
Where
1 siteChina
Study dates
25 May 2021to 31 Jul 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Adults aged 18-55 who need and suitable anterior cruciate ligament reconstruction

Who may be able to join

  • Adults aged 18-55 who need anterior cruciate ligament reconstruction

Who cannot join

  • Volunteers unsuitable for anterior cruciate ligament reconstruction

Trial locations and contacts

1 site in 1 country.

Yong Ma, M.D. contact

13581945087

huidong01@sina.com

Weili Shi, M.D. contact

18046529457

shiweilixmu@126.com

China1 site, 1 recruiting
  • Ma Yong

    Beijing, Beijing Municipality, 100000

    Weili Shi, M.D., +8618046529457, shiweilixmu@126.com

    Recruiting

Other trials in China

About this study

Official title: The Role of the Apex of the Deep Cartilage in Assessing Femoral Tunnel Position for Anterior Cruciate Ligament Reconstruction

To examine the consistency between postoperative CT scan and intraoperative arthroscopic measurement in evaluating femoral tunnel position for anterior cruciate ligament (ACL)reconstruction,both using the apex of the deep cartilage(ADC)as the marker.

Read the detailed description

The position of the center of femoral tunnel was decided in the complete femoral stub. Then the length from the ADC to the anterior cartilage margin(L1)and to the center of femoral tunnel(l1),as well as the center to the distal cartilage margin(D1)were measured under arthroscopy and on post-operative CT scan(L2,l2 and D2). Moreover,P1 and P2 were calculated through l1/L1 and l2/L2.

Conditions
ACL Injury
Keywords
femoral tunnel, apex of the deep cartilage(ADC)
Medical subject headings
Anterior Cruciate Ligament Injuries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. length from ADC to anterior cartilage margin (L1) under arthroscopy

    length from ADC to anterior cartilage margin (L1) under arthroscopy

    Measured: during operation

  2. length from ADC to the center of femoral tunnel (l1) under arthroscopy

    length from ADC to the center of femoral tunnel (l1) under arthroscopy

    Measured: during operation

  3. length from the center of femoral tunnel to the distal cartilage margin(D1) under arthroscopy

    length from the center of femoral tunnel to the distal cartilage margin(D1) under arthroscopy

    Measured: during operation

  4. length from ADC to anterior cartilage margin (L2) on CT

    length from ADC to anterior cartilage margin (L2) on CT

    Measured: 1 day after operation

  5. length from ADC to the center of femoral tunnel (l1) on CT

    length from ADC to the center of femoral tunnel (l1) on CT

    Measured: 1 day after operation

  6. length from the center of femoral tunnel to the distal cartilage margin(D1) on CT

    length from the center of femoral tunnel to the distal cartilage margin(D1) on CT

    Measured: 1 day after operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2021
  2. Study start25 May 2021
  3. Primary completion31 Jul 2021 (estimated)
  4. Study completion31 Jul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04937517
Sponsor's protocol ID
ADC
Status last verified
Jun 2021
First submitted
16 Jun 2021
Last updated
24 Jun 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Publication of academic papers

Publications

  • Hofbauer M, Muller B, Murawski CD, van Eck CF, Fu FH. The concept of individualized anatomic anterior cruciate ligament (ACL) reconstruction. Knee Surg Sports Traumatol Arthrosc. 2014 May;22(5):979-86. doi: 10.1007/s00167-013-2562-4. Epub 2013 Jun 6.

    PubMed 23740328
  • Inderhaug E, Larsen A, Strand T, Waaler PA, Solheim E. The effect of feedback from post-operative 3D CT on placement of femoral tunnels in single-bundle anatomic ACL reconstruction. Knee Surg Sports Traumatol Arthrosc. 2016 Jan;24(1):154-60. doi: 10.1007/s00167-014-3355-0. Epub 2014 Oct 2.

    PubMed 25274095
  • Hart A, Han Y, Martineau PA. The Apex of the Deep Cartilage: A Landmark and New Technique to Help Identify Femoral Tunnel Placement in Anterior Cruciate Ligament Reconstruction. Arthroscopy. 2015 Sep;31(9):1777-83. doi: 10.1016/j.arthro.2015.03.026. Epub 2015 May 15.

    PubMed 25980920
  • Shi W, Zhang J, Meng Q, Chen N, Shen Q, Li S, Cao Z, Ao Y, Ma Y. The apex of the deep cartilage is a stable landmark to evaluate the femoral tunnel position in ACL reconstruction. Knee Surg Sports Traumatol Arthrosc. 2023 Jan;31(1):256-263. doi: 10.1007/s00167-022-07090-4. Epub 2022 Aug 13.

    PubMed 35962841

Questions about this trial

What is this clinical trial studying?

An observational study of ACL Injury, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yong Ma, M.D. (13581945087, huidong01@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

length from ADC to anterior cartilage margin (L1) under arthroscopy (time frame: during operation). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04937517, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in